FR3080763B1 - TOPICAL COMPOSITION FOR SURFACE BURNS - Google Patents

TOPICAL COMPOSITION FOR SURFACE BURNS Download PDF

Info

Publication number
FR3080763B1
FR3080763B1 FR1800432A FR1800432A FR3080763B1 FR 3080763 B1 FR3080763 B1 FR 3080763B1 FR 1800432 A FR1800432 A FR 1800432A FR 1800432 A FR1800432 A FR 1800432A FR 3080763 B1 FR3080763 B1 FR 3080763B1
Authority
FR
France
Prior art keywords
topical composition
surface burns
burns
water
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1800432A
Other languages
French (fr)
Other versions
FR3080763A1 (en
Inventor
Lara Baudonnet
Marie-Florence Galliano
Sophie Blanco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR1800432A priority Critical patent/FR3080763B1/en
Priority to EP19725037.6A priority patent/EP3787608A1/en
Priority to PCT/EP2019/061419 priority patent/WO2019211455A1/en
Publication of FR3080763A1 publication Critical patent/FR3080763A1/en
Application granted granted Critical
Publication of FR3080763B1 publication Critical patent/FR3080763B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition à usage topique comprenant, en tant association de glycérol, d'un émollient et un sel d'acide hyaluronique sous forme d'une émulsion huile dans eau ou eau dans huile ainsi que son utilisation pour le traitement des brûlures superficielles de faibles étendues.The invention relates to a composition for topical use comprising, as a combination of glycerol, an emollient and a salt of hyaluronic acid in the form of an oil-in-water or water-in-oil emulsion, as well as its use for the treatment of burns. shallow in small areas.

FR1800432A 2018-05-04 2018-05-04 TOPICAL COMPOSITION FOR SURFACE BURNS Active FR3080763B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1800432A FR3080763B1 (en) 2018-05-04 2018-05-04 TOPICAL COMPOSITION FOR SURFACE BURNS
EP19725037.6A EP3787608A1 (en) 2018-05-04 2019-05-03 Topical composition for superficial burns
PCT/EP2019/061419 WO2019211455A1 (en) 2018-05-04 2019-05-03 Topical composition for superficial burns

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1800432A FR3080763B1 (en) 2018-05-04 2018-05-04 TOPICAL COMPOSITION FOR SURFACE BURNS
FR1800432 2018-05-04

Publications (2)

Publication Number Publication Date
FR3080763A1 FR3080763A1 (en) 2019-11-08
FR3080763B1 true FR3080763B1 (en) 2020-11-27

Family

ID=62683267

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1800432A Active FR3080763B1 (en) 2018-05-04 2018-05-04 TOPICAL COMPOSITION FOR SURFACE BURNS

Country Status (3)

Country Link
EP (1) EP3787608A1 (en)
FR (1) FR3080763B1 (en)
WO (1) WO2019211455A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005040403A (en) * 2003-07-23 2005-02-17 Shiseido Co Ltd Beauty treatment method for sensitive skin
US20100080768A1 (en) * 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
FR3013985B1 (en) * 2013-12-03 2017-11-03 Galephar M/F MOISTURIZING COMPOSITIONS COMPRISING AT LEAST ONE CAESALPINIA SPINOSA EXTRACT WITH AT LEAST VASELIN AND GLYCERIN
US10496949B2 (en) * 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions

Also Published As

Publication number Publication date
EP3787608A1 (en) 2021-03-10
WO2019211455A1 (en) 2019-11-07
FR3080763A1 (en) 2019-11-08

Similar Documents

Publication Publication Date Title
MA47399B1 (en) Derivatives of 7-phenylethylamino-4h-pyrimido [4,5-d] [1,3] oxazin-2-one as inhibitors of the mutated form of idh1 and idh2 proteins
MA42279A (en) COMPOSITIONS INCLUDING A BACTERIAL STRAIN OF BLAUTIA HYDROGENOTROPHICA FOR USE FOR THE PREVENTION OR TREATMENT OF DIARRHEA OR CONSTIPATION
FR3041251B1 (en) COMPOSITIONS IN THE FORM OF OIL-IN-WATER EMULSIONS WHOSE FATTY PHASE IS IN THE FORM OF DROPS
MA40306A1 (en) Methods and formulations for the treatment of vascular ocular pathologies
MA53937A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
MA38425A1 (en) Bicyclic compounds for use as selective agonists for the s1p1 receptor
FR3099058B1 (en) Use of a glycine betaine derivative as a hair conditioning agent
FR3088542B1 (en) Healing composition comprising electrolyzed water
EA201890119A1 (en) MIXED COMPOSITIONS
FR3018190B1 (en) LIGHTENING COSMETIC COMPOSITION
FR3080763B1 (en) TOPICAL COMPOSITION FOR SURFACE BURNS
FR3045343B1 (en) OXIDIZING COMPOSITION COMPRISING AT LEAST 30% SURFACTANTS
MX2020005055A (en) Emulsions for treating mucous membrane infections.
MA54276B1 (en) MONTELUKAST FOR THE TREATMENT OF HAND OSTEOARTHRITIS
MA57099B1 (en) Composition of zeolite suitable for tanning leather
FR3047665B1 (en) CELASTROL AND ITS DERIVATIVES IN THE TREATMENT OF PRE-CANCEROUS SKIN TUMORS AND PATHOLOGIES
MA33318B1 (en) The composition of a laxative for preventive treatment of atopic dermatitis
FR3031301B1 (en) NOVEL COMPOSITION COMPRISING CHROMIUM AND TYROSINE DERIVATIVES FOR THE TREATMENT OF SKIN
MA56608B1 (en) Composition and use of an ophthalmic solution based on hyaluronic acid and arabinogalactan
MA51612B1 (en) Ophthalmic compositions comprising bilastin, a beta-cyclodextrin and at least one gelling agent
FR3095588B1 (en) New topical formulation modulating the pathways of nociception
MA39805A (en) BIOLOGICAL BARRIER WITH SIMETHICONE FOR USE IN THE TREATMENT OF NASO-PHARYNGO-TUBAL INFECTIONS
FR3070605B1 (en) LOW MOLECULAR WEIGHT POLYETHYLENE-IMINE AS AN ANTI-PERSPIRANT ACTIVE INGREDIENT AS AN O / W EMULSION
FR3080764B1 (en) COMBINATION OF EXTRACTS OF QUINQUINA AND LEONTOPODIUM ALPINUM AND MANGANESE SALT OF L-PYRROLIDONE CARBOXYLIC ACID FOR THE TREATMENT OF ALOPECIA
FR3065372B1 (en) COMPOSITION COMPRISING CARBOXY METHYL NARINGENINE CHALCONE FOR THE TREATMENT OF PRURITUS AND ATOPIC DERMATITIS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20191108

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6